DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Adherence of Stalevo, Entacapone and Levodopa

Information source: South Glasgow University Hospitals NHS Trust
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Parkinson's Disease

Phase: N/A

Status: Completed

Sponsored by: South Glasgow University Hospitals NHS Trust

Official(s) and/or principal investigator(s):
Donald G Grosset, MBChB, MD, Principal Investigator

Summary

To test if combining two antiparkinson drugs into a single tablet improves accuracy of medicine intake by the patient. To test if patients with Parkinson's disease who take medicines at regular time intervals have smoother symptom control.

Clinical Details

Official title: Study of Adherence of Stalevo, Entacapone and Levodopa

Study design: N/A

Eligibility

Minimum age: 18 Years. Maximum age: 85 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients diagnosed with Parkinson's disease aged between 18 and 85 years fulfilling

UK Brain Bank criteria.

- Current levodopa therapy prescribed on a regular basis three or more times per day

but requiring entacapone because of 'wearing off'

- Able to manipulate electronic monitoring bottles and complete questionnaires

Exclusion Criteria:

- Current use of compliance aid such that study participation would be detrimental to

patient's adherence

- Pregnancy or breast feeding

- Excess alcohol (over 21 units per week for women and 28 units for men)

- Mini mental state examination of less than 26.

- Severe depression (Geriatric depression score over 20)

Locations and Contacts

Southern General Hospital, Glasgow, Scotland G51 4TF, United Kingdom
Additional Information

Starting date: April 2005
Last updated: May 22, 2008

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017